Validation of Centers for Disease Control and Prevention National Wastewater Surveillance System’s Wastewater Viral Activity Level for Respiratory Viruses, 2025 –2026 Respiratory Season

Background The Centers for Disease Control and Prevention (CDC) developed the Wastewater Viral Activity Level metric (WVAL) for SARS-CoV-2 in 2023 to meet the need for a public metric that aggregates wastewater viral RNA concentration data to provide jurisdictional, regional, and national surveillance system estimates for the United States. The WVAL was expanded in August 2024 to include virus-specific metrics for influenza A and respiratory syncytial virus (RSV). This paper describes results the 2025 validation of the updated WVAL methodology. Methods During validation conducted from March through July 2025, candidate WVAL methods were evaluated using wastewater surveillance data collected through March 22, 2025, from SARS-CoV-2, influenza A, and RSV sampling sites. Evaluated components included the baseline calculation and stabilization period, the frequency of baseline and standard deviation updates, the sample look-back period used to calculate the baseline, and the cut points used to assign WVAL categories. Results Data included 4,447 SARS-CoV-2, 1,592 influenza A, and 1,454 RSV data submitter level sampling sites. A z-score threshold of 4 was selected for outlier removal, and non-normalized wastewater concentrations with a 24-month look-back period were selected for baseline and standard deviation calculations across pathogens. Baseline and standard deviation updates were scheduled for April 1 and October 1 for SARS-CoV-2 and August 1 for influenza A and RSV. An eight-week stabilization period was selected. Median-of-medians aggregation was selected for regional and national estimates, and pathogen-specific cut-points were selected to align WVAL categories with clinical surveillance data. National WVALs were moderately to strongly correlated with emergency department surveillance data for SARS-CoV-2 (Kendall’s tau = 0.78), influenza A (0.81), and RSV (0.74). Conclusions Annual validation supported updates to the WVAL methodology that reduced extreme values, improved comparability across pathogens and geographic levels, and maintained alignment with clinical surveillance. The updated methods provide a more consistent framework for public wastewater surveillance of SARS-CoV-2, influenza A, and RSV.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11625409/v1
Primary Topic
SARS-CoV-2 detection and testing
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Validation of Centers for Disease Control and Prevention National Wastewater Surveillance System’s Wastewater Viral Activity Level for Respiratory Viruses, 2025 –2026 Respiratory Season

Megan Bias, Alexia Couture, Megan E. Gerdes, Heather E. Reese et al.
Research Square
SARS-CoV-2 detection and testing
preprint

Validation of Centers for Disease Control and Prevention National Wastewater Surveillance System’s Wastewater Viral Activity Level for Respiratory Viruses, 2025 –2026 Respiratory Season

Megan Bias, Alexia Couture, Megan E. Gerdes, Heather E. Reese, Alicia Budd, Elisabeth Burnor, Kirsten Weisbeck, Nathan C. LaCross, Matthew Biggerstaff, Benjamin J. Silk, Dennis Nichols, Lisa P. Oakley, Rebecca Schneider, Jenna Webb, Dustin Servello, Igor Volkov, Erin Anderson, Bradie Ahern, Alexandra Busbee, Dan Cornforth
preprint en

Abstract

Background The Centers for Disease Control and Prevention (CDC) developed the Wastewater Viral Activity Level metric (WVAL) for SARS-CoV-2 in 2023 to meet the need for a public metric that aggregates wastewater viral RNA concentration data to provide jurisdictional, regional, and national surveillance system estimates for the United States. The WVAL was expanded in August 2024 to include virus-specific metrics for influenza A and respiratory syncytial virus (RSV). This paper describes results the 2025 validation of the updated WVAL methodology. Methods During validation conducted from March through July 2025, candidate WVAL methods were evaluated using wastewater surveillance data collected through March 22, 2025, from SARS-CoV-2, influenza A, and RSV sampling sites. Evaluated components included the baseline calculation and stabilization period, the frequency of baseline and standard deviation updates, the sample look-back period used to calculate the baseline, and the cut points used to assign WVAL categories. Results Data included 4,447 SARS-CoV-2, 1,592 influenza A, and 1,454 RSV data submitter level sampling sites. A z-score threshold of 4 was selected for outlier removal, and non-normalized wastewater concentrations with a 24-month look-back period were selected for baseline and standard deviation calculations across pathogens. Baseline and standard deviation updates were scheduled for April 1 and October 1 for SARS-CoV-2 and August 1 for influenza A and RSV. An eight-week stabilization period was selected. Median-of-medians aggregation was selected for regional and national estimates, and pathogen-specific cut-points were selected to align WVAL categories with clinical surveillance data. National WVALs were moderately to strongly correlated with emergency department surveillance data for SARS-CoV-2 (Kendall’s tau = 0.78), influenza A (0.81), and RSV (0.74). Conclusions Annual validation supported updates to the WVAL methodology that reduced extreme values, improved comparability across pathogens and geographic levels, and maintained alignment with clinical surveillance. The updated methods provide a more consistent framework for public wastewater surveillance of SARS-CoV-2, influenza A, and RSV.

Research Square
Washington State Department of Health (US), Centers for Disease Control and Prevention (US), Booz Allen Hamilton (United States) (US), Colorado Department of Public Health and Environment (US), California Department of Public Health (US), Ohio Department of Health (US), Houston Health and Human Services Department (US), State of Washington (US), Utah Department of Health and Human Services (US)
SARS-CoV-2 detection and testing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon